ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 124,74
-0,10%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Inhibrx Biosciences Inc (INBX)

  7. Inhibrx Biosciences Inc (INBX) Actualités

INBX Inhibrx Biosciences Inc

15,70
-0,89 (-5,36%)
14 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Inhibrx Biosciences Inc INBX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,89 -5,36% 15,70 22:12:39
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
16,44 15,65 16,65 15,70 16,59
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
31/5/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:34EDGAR2Form S-8 POS - Securities to be offered to employees in..
30/5/202422:32EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
30/5/202422:13EDGAR2Form 8-K - Current report
28/5/202422:55EDGAR2Form 144 - Report of proposed sale of securities
25/5/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/5/202422:08EDGAR2Form 8-K - Current report
24/5/202422:00PRNUSInhibrx Inc. Stockholders Approve Sale of INBRX-101 to..
22/5/202415:54EDGAR2Form 144 - Report of proposed sale of securities
21/5/202403:48EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/5/202423:29EDGAR2Form 8-K - Current report
17/5/202422:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/5/202400:36PRNUSInhibrx, Inc. Announces Updated When-Issued Trading Date for..
09/5/202422:08EDGAR2Form 8-K - Current report
08/5/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202422:42EDGAR2Form 8-K - Current report
08/5/202422:37PRNUSInhibrx, Inc. Announces Record Date and Expected..
06/5/202423:16EDGAR2Form 144 - Report of proposed sale of securities
11/3/202421:26EDGAR2Form 144 - Report of proposed sale of securities
08/3/202422:08EDGAR2Form 144 - Report of proposed sale of securities
08/3/202421:28EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202420:58EDGAR2Form 144 - Report of proposed sale of securities
05/3/202400:26EDGAR2Form 144 - Report of proposed sale of securities
29/2/202423:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
28/2/202415:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
28/2/202415:12EDGAR2Form 8-K - Current report
28/2/202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/2/202422:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202422:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/1/202418:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
23/1/202423:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202412:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202412:35EDGAR2Form 8-K - Current report
23/1/202412:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23/1/202411:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
23/1/202407:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
09/11/202322:03EDGAR2Form 8-K - Current report
09/11/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
02/11/202314:16EDGAR2Form 8-K - Current report
02/11/202314:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
18/10/202322:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
19/9/202322:03EDGAR2Form 8-K - Current report
19/9/202322:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
29/8/202315:03EDGAR2Form 8-K - Current report
29/8/202315:00PRNUSInhibrx Announces $200 Million Private Placement Financing
07/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dernières Valeurs Consultées

NASDAQ
INBX
Inhibrx Biosciences
USOTC
ABXWF
Abaxx Technologies (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés